Pharm@dvice
ActiveDeeds, filings and financial milestones
Deadline for the 2026 accounts:
2026
28-09
abbreviated format · 59 days late
2025
14-08
full format · 14 days late
2024
08-05
full format · 84 days before the deadline
11-01
Gazette deed
Company renamed from PHARMA DEHAYBE to Pharm@dviceResignation: Jérôme DEHAYBE (director) · Appointment: PVC INVEST (director) · Permanent representative: Philippe VAN WAUWENBERGE9 points ▸
Gazette deed
Company renamed from PHARMA DEHAYBE to Pharm@dvice
Resignation: Jérôme DEHAYBE (director) · Appointment: PVC INVEST (director) · Permanent representative: Philippe VAN WAUWENBERGE9 points ▸
- General meeting, 09-01-2024
- Legal-form conversion, from private limited company (pre-2019) to private limited company
- Name change, Pharm@dvice
- 100 shares
- Director resignation, Jérôme DEHAYBE
- Director discharge, Jérôme DEHAYBE
- Director appointment, PVC INVEST
- Permanent representative, Philippe VAN WAUWENBERGE
- Power of attorney, Manon Deprez
- The deed holds 6 more points.
2023
26-07
full format · 5 days before the deadline
2022
31-12
Financial
Highest result from 2018 to 2025net €49,482 ▲29.7%
The operating result of €63,730 and the net result of €49,482 are both a record.
14-06
full format · 47 days before the deadline
2021
20-07
full format · 11 days before the deadline
2020
31-12
Financial
Back to profitnet €25,901
The net result is €25,901, after 2 loss-making years.
15-07
full format · 16 days before the deadline
2019
08-07
full format · 23 days before the deadline
2018
12-07
full format · 19 days before the deadline
2017
09-05
full format · 83 days before the deadline
2010
13-09
Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
Sources:Publications in the Belgian Official GazetteFilings with the National Bank